Human Pluripotent Stem Cell-derived Cortical Neurons for High Throughput Medication Screening in Autism: A Proof of Concept Study in SHANK3 Haploinsufficiency Syndrome

MLA

Hélène Darville, et al. “Human Pluripotent Stem Cell-Derived Cortical Neurons for High Throughput Medication Screening in Autism: A Proof of Concept Study in SHANK3 Haploinsufficiency Syndrome.” EBioMedicine, vol. 9, no. C, July 2016, pp. 293–305. EBSCOhost, https://doi.org/10.1016/j.ebiom.2016.05.032.

APA

Hélène Darville, Aurélie Poulet, Frédérique Rodet-Amsellem, Laure Chatrousse, Julie Pernelle, Claire Boissart, Delphine Héron, Caroline Nava, Anselme Perrier, Margot Jarrige, Francis Cogé, Mark J. Millan, Thomas Bourgeron, Marc Peschanski, Richard Delorme, & Alexandra Benchoua. (2016). Human Pluripotent Stem Cell-derived Cortical Neurons for High Throughput Medication Screening in Autism: A Proof of Concept Study in SHANK3 Haploinsufficiency Syndrome. EBioMedicine, 9(C), 293–305. https://doi.org/10.1016/j.ebiom.2016.05.032

Chicago

Hélène Darville, Aurélie Poulet, Frédérique Rodet-Amsellem, Laure Chatrousse, Julie Pernelle, Claire Boissart, Delphine Héron, et al. 2016. “Human Pluripotent Stem Cell-Derived Cortical Neurons for High Throughput Medication Screening in Autism: A Proof of Concept Study in SHANK3 Haploinsufficiency Syndrome.” EBioMedicine 9 (C): 293–305. doi:10.1016/j.ebiom.2016.05.032.